Microbiome Sequencing Outsourcing Services Market Size, Share & Trends Report

Microbiome Sequencing Outsourcing Services Market Size, Share & Trends Analysis Report By Application (Shotgun Sequencing), Laboratory Type (Wet Labs), By End-Use, By Region, And Segment Forecasts, 2022 To 2030

Report ID: GVR453677
Number of Pages: 0
Format: Electronic (PDF)

Historical Data: ---
Industry: Healthcare

Table of Content

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Application
  1.1.2. Laboratory Type
  1.1.3. End Use
  1.1.4. Regional scope
  1.1.5. Estimates and forecast timeline
  1.2. Research Methodology
  1.3. Information Procurement
  1.3.1. Purchased database
  1.3.2. GVR’s internal database
  1.3.3. Secondary sources
  1.3.4. Primary research
  1.4. Information or Data Analysis
  1.4.1. Data analysis models
  1.5. Market Formulation & Validation
  1.6. Model Details
  1.6.1. Commodity flow analysis (Model 1)
  1.6.2. Volume price analysis (Model 2)
  1.7. List of Secondary Sources
  1.8. List of Primary Sources
  1.9. Objectives
  1.9.1. Objective 1
  1.9.2. Objective 2
  1.9.3. Objective 3
  1.9.4. Objective 4
Chapter 2. Executive Summary
  2.1. Market Outlook
Chapter 3. Microbiome Sequencing Outsourcing Services Market Variables, Trends & Scope
  3.1. Market Lineage Outlook
  3.1.1. Parent market outlook
  3.1.2. Related/ancillary market outlook
  3.2. Market Dynamics
  3.2.1. Market driver analysis
  3.2.2. Market restraint analysis
  3.3. Penetration & Growth Prospect Mapping
  3.4. Covid-19 Impact & Recovery Analysis
  3.5. Major Deals and Strategic Alliances Analysis
  3.6. Industry Analysis – Porter’s
  3.7. PESTLE Analysis
Chapter 4. Microbiome Sequencing Outsourcing Services Market: Application Analysis
  4.1. Microbiome Sequencing Outsourcing Services Market: Definition & Scope
  4.2. Microbiome Sequencing Outsourcing Services Market: Application Market Share Analysis, 2022 & 2030
  4.2.1. Shotgun Sequencing
4.2.1.1. Shotgun Sequencing Market, 2018 – 2030 (USD Million)
  4.2.2. Targeted Gene Sequencing
  4.2.2.1. Targeted Gene Sequencing Market, 2018 - 2030 (USD Million)
  4.2.3. RNA Sequencing
  4.2.3.1. RNA Sequencing Market, 2018 - 2030 (USD Million)
  4.2.4. Others
  4.2.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Microbiome Sequencing Outsourcing Services Market: End Use Segment Analysis
  5.1. Microbiome Sequencing Outsourcing Services Market: Definition & Scope
  5.2. Microbiome Sequencing Outsourcing Services Market: End Use Market Share Analysis, 2022 & 2030
  5.2.1. Pharmaceutical & Biopharmaceutical Companies
  5.2.1.1. Pharmaceutical & Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
  5.2.2. Academic/ Research Institute
  5.2.2.1. Academic / Research Institute Market, 2018 - 2030 (USD Million)
Chapter 6. Microbiome Sequencing Outsourcing Services Market: Laboratory Type Segment Analysis
  6.1. Microbiome Sequencing Outsourcing Services Market: Definition & Scope
  6.2. Microbiome Sequencing Outsourcing Services Market Laboratory Type Market Share Analysis, 2022 & 2030
  6.2.1. Wet Labs
  6.2.1.1. Wet Labs Market, 2018 - 2030 (USD Million)
  6.2.2. Dry Labs
  6.2.2.1. Dry Labs Market, 2018 - 2030 (USD Million)
Chapter 7. Microbiome Sequencing Outsourcing Services Market: Regional Analysis
  7.1. Microbiome Sequencing Outsourcing Services: Regional market share analysis, 2022 & 2030
  7.2. North America
  7.2.1. North America Market estimates and forecast, 2018 - 2030
  7.2.2. U.S.
  7.2.2.1. U.S. Market estimates and forecast, 2018 - 2030
  7.2.3. Canada
  7.2.3.1. Canada Market estimates and forecast, 2018 - 2030
  7.3. Europe
  7.3.1. Europe Market estimates and forecast, 2018 - 2030
  7.3.2. UK
  7.3.2.1. UK Market estimates and forecast, 2018 - 2030
  7.3.3. Germany
  7.3.3.1. Germany Market estimates and forecast, 2018 - 2030
  7.3.4. France
  7.3.4.1. France Market estimates and forecast, 2018 - 2030
  7.3.5. Italy
  7.3.5.1. Italy Market estimates and forecast, 2018 - 2030
  7.3.6. Spain
  7.3.6.1. Spain Market estimates and forecast, 2018 - 2030
  7.3.7. Denmark
  7.3.7.1. Denmark Market estimates and forecast, 2018 - 2030
  7.3.8. Sweden
  7.3.8.1. Sweden Market estimates and forecast, 2018 - 2030
  7.3.9. Norway
  7.3.9.1. Norway Market estimates and forecast, 2018 - 2030
  7.4. Asia Pacific
  7.4.1. Asia Pacific Market estimates and forecast, 2018 - 2030
  7.4.2. Japan
  7.4.2.1. Japan Market estimates and forecast, 2018 - 2030
  7.4.3. China
  7.4.3.1. China Market estimates and forecast, 2018 - 2030
  7.4.4. India
  7.4.4.1. India Market estimates and forecast, 2018 - 2030
  7.4.5. South Korea
  7.4.5.1. South Korea Market estimates and forecast, 2018 - 2030
  7.4.6. Thailand
  7.4.6.1. Thailand Market estimates and forecast, 2018 - 2030
  7.4.7. Australia
  7.4.7.1. Australia Market estimates and forecast, 2018 - 2030
  7.5. Latin America
  7.5.1. Latin America Market estimates and forecast, 2018 - 2030
  7.5.2. Brazil
  7.5.2.1. Brazil Market estimates and forecast, 2018 - 2030
  7.5.3. Mexico
  7.5.3.1. Mexico Market estimates and forecast, 2018 - 2030
  7.5.4. Argentina
  7.5.4.1. Argentina Market estimates and forecast, 2018 - 2030
  7.6. MEA
  7.6.1. MEA Market estimates and forecast, 2018 - 2030
  7.6.2. South Africa
  7.6.2.1. South Africa Market estimates and forecast, 2018 - 2030
  7.6.3. Saudi Arabia
  7.6.3.1. Saudi Arabia Market estimates and forecast, 2018 - 2030
  7.6.4. UAE
  7.6.4.1. UAE Market estimates and forecast, 2018 - 2030
  7.6.5. Kuwait
  7.6.5.1. Kuwait Market estimates and forecast, 2018 - 2030
Chapter 8. Competitive Landscape
  8.1. Company Market Share Analysis, 2022
  8.2. Company Profiles
  8.2.1. Clinical Microbiomics
  8.2.1.1. Company overview
  8.2.1.2. Financial performance
  8.2.1.3. Service benchmarking
  8.2.1.4. Strategic initiatives
  8.2.2. Zymo Research Corp.
  8.2.2.1. Company overview
  8.2.2.2. Financial performance
  8.2.2.3. Service benchmarking
  8.2.2.4. Strategic initiatives
  8.2.3. Microbiome Therapeutics, LLC.
  8.2.3.1. Company overview
  8.2.3.2. Financial performance
  8.2.3.3. Service benchmarking
  8.2.3.4. Strategic initiatives
  8.2.4. Microbiome Insights Inc.
  8.2.4.1. Company overview
  8.2.4.2. Financial performance
  8.2.4.3. Service benchmarking
  8.2.4.4. Strategic initiatives
  8.2.5. MR DNA ( Molecular Research LP)
  8.2.5.1. Company overview
  8.2.5.2. Financial performance
  8.2.5.3. Service benchmarking
  8.2.5.4. Strategic initiatives
  8.2.6. Merieux Nutrisciences Corp
  8.2.6.1. Company overview
  8.2.6.2. Financial performance
  8.2.6.3. Service benchmarking
  8.2.6.4. Strategic initiatives
  8.2.7. Metabiomics Corp.
  8.2.7.1. Company overview
  8.2.7.2. Financial performance
  8.2.7.3. Service benchmarking
  8.2.7.4. Strategic initiatives
  8.2.8. Baseclear B.V.
  8.2.8.1. Company overview
  8.2.8.2. Financial performance
  8.2.8.3. Service benchmarking
  8.2.8.4. Strategic initiatives
  8.2.9. Rancho Biosciences
  8.2.9.1. Company overview
  8.2.9.2. Financial performance
  8.2.9.3. Service benchmarking
  8.2.9.4. Strategic initiatives
  8.2.10. Illumina, Inc.
  8.2.10.1. Company overview
  8.2.10.2. Financial performance
  8.2.10.3. Service benchmarking
  8.2.10.4. Strategic initiatives

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.